Skip to main content
. 2021 Sep 17;12:712492. doi: 10.3389/fpsyt.2021.712492

Table 1.

Overview of sex- and gender-stratified assessed outcome variables in all studies.

Variable Frequency total (group specific results)
Main outcomes
COVID-19 specific fear, anxiety, or worry 17 (1 m/15 w/0 d/1 n.s.)
Health anxiety 1 (1 w)
General anxiety (state & trait) 30 (2 m/22 w/1 d/5 n.s.)
Depression symptoms 31 (0 m/22 w/2 d/7 n.s.)*
Suicidal ideation 5 (1 m/2 w/0 d/2 n.s.)
Peri- & post-traumatic stress symptoms 12 (3 m/6 w/0 d/3 n.s.)
Insomnia and sleep problems 6 (1 m/3 w/0 d/2 n.s.)
Stress 26 (0 m/21 w/2 d/3 n.s.)*
Fatigue/burnout 2 (2 w)
Somatic symptom load 5 (0 m/2 w/1 d/2 n.s.)*
Other mental disorders 1 (1 n.s.)
Loneliness 1 (1 d)*
Positive mental health, well-being, life satisfaction 3 (2 m/0 w/0 d/1 n.s.)
Resilience 1 (1 m)
Mindfulness 1 (1 w)
Additional outcomes
Hospitalization 1 (1 m)
Perceived high susceptibility to COVID-19 9 (1 m/5 w/0 d/3 n.s.)
Time spent with COVID-19 news 3 (0 m/1 w/0 d/2 n.s.)
Use of general stress coping strategies during COVID-19 4 (0 m/2 w/0 d/2 n.s.)
Worse diet & eating behavior 3 (3 w)
Smoking habit 1 (1 n.s.)
Alcohol consumption 1 (1 w)
Physical activity 3 (2 m/0 w/0 d/1 n.s.)
Confidence in use of coping strategy 5 (1 m/4 w/0 d/0 n.s.)
Belief in having sufficient knowledge & information about COVID-19 3 (1 m/0 w/0 d/2 n.s.)
COVID-19 guideline adherence/ preventive measures 12 (1 m/10 w/0 d/1 n.s.)

Group specific results reported in parentheses indicate which group reports higher scores on each defined outcome. M, men; w, women; d, non-binary, diverse; n. s., no significant difference. Italic outcomes are positively connotated. Asterix* = includes cases in which non-binary sex or diverse gender reported higher scores, but were excluded in main analyses due to small group size for inference statistical comparison; for details see Table 2.